Osteologie 2024; 33(01): 43-48
DOI: 10.1055/a-2161-7349
Case Report

Hyperostosis of the Clavicle as a Cardinal Symptom for Sapho Syndrome – Presentation and Discussion of a Clinical Case

Hyperostose der Klavikula als ein Kardinalsymptom für das SAPHO-Syndrom – Präsentation und Diskussion eines klinischen Fallberichtes
1   Department of Orthopedics and Trauma Surgery, Medical University of Vienna, Vienna, Austria
,
Justyna Reinke
2   Clinic of Trauma and Restorative Surgery, Charité University Medicine, Campus Benjamin Franklin, Berlin, Germany
,
Sebastian Radmer
3   Specialist practice for orthopedics, Centre for Orthopaedics, Berlin, Germany
› Author Affiliations

Abstract

SAPHO syndrome comprises a broad clinical spectrum and is based on inflammatory osteitis with or without association to a dermatological affection. A young man with chronic recurrent osteomyelitis (CRMO) of the right clavicle as a cardinal symptom of SAPHO syndrome is reported on. Whole-body MRI has proven effective for focal detection and assessment of local activity of a possible multifocal manifestation of CRMO. Multiple medication with NSAIDs, a bisphosphonate, vitamin D substitution and antibiosis resulted in extensive remission of symptoms. Biologicals can also be used if there is no effect. The terminology of chronic nonbacterial osteomyelitis (CNO) in connection with the SAPHO syndrome is discussed.

Zusammenfassung

Das SAPHO-Syndrom umfasst ein breites klinisches Spektrum und beruht auf einer entzündlichen Osteitis mit oder ohne Assoziation zu einer dermatologischen Affektion. Es wird über einen jungen Mann mit einer chronisch rekurrierenden Osteomyelitis (CRMO) der rechten Klavikula als ein Kardinalsymptom für das SAPHO-Syndrom berichtet. Zur Fokussuche und Beurteilung einer lokalen Aktivität einer möglichen multifokalen Manifestation der CRMO hat sich das Ganzkörper-MRT bewährt. Eine multifaktorielle Medikation mit NSAR, einem Bisphosphonat, einer Vitamin D Substitution und einer Antibiose führten zu einer weitgehenden Remission der Beschwerden. Biologika können bei einem ausbleibenden Effekt zusätzlich zum Einsatz kommen. Auf die Begrifflichkeit der chronischen nichtbakteriellen Osteomyelitis (CNO) im Zusammenhang mit dem SAPHO-Syndrom wird eingegangen.



Publication History

Received: 25 June 2023

Accepted: 28 August 2023

Article published online:
06 October 2023

© 2023. Thieme. All rights reserved.

Georg Thieme Verlag
Rüdigerstraße 14, 70469 Stuttgart, Germany

 
  • References

  • 1 Chamot AM, Benhamou CL, Kahn MF, Beraneck L, Kaplan G, Prost A. Le syndrome acné pustulose hyperostose ostéite (SAPHO). Résultats d’une enquête nationale. 85 observations. Rev Rhum Mal Osteoartic 1987; 54: 187-196 PMID: 2954204
  • 2 Liu S, Tang M, Cao Y, Li C. Synovitis, acne, pustulosis, hyperostosis, and osteitis syndrome: review and update. Ther Adv Musculoskelet Dis 2020; 12: 1759720X20912865 DOI: 10.1177/1759720X20912865.
  • 3 Schilling F, Kessler S. [SAPHO syndrome: clinico-rheumatologic and radiologic differentiation and classification of a patient sample of 86 cases]. Z Rheumatol 2000; 59: 1-28 German DOI: 10.1007/s003930050001.
  • 4 Sartoris DJ, Schreiman JS, Kerr R, Resnik CS, Resnick D. Sternocostoclavicular hyperostosis: a review and report of 11 cases. Radiology 1986; 158: 125-128 DOI: 10.1148/radiology.158.1.3940368.
  • 5 Schilling F, Kessler S, Eckardt A, Stofft E. [„Sympathetic Arthritis” – A symptom of chronic recurrent multifocal osteomyelitis (CRMO)]. Akt Rheumatol 2001; 26: 61-74 German DOI: 10.1055/s-2001-14221.
  • 6 Klemm P, Lange U. [SAPHO syndrome: An overview and nosological differentiation of 35 disease cases]. Z Rheumatol 2021; 80: 456-466 German DOI: 10.1007/s00393-021-00979-4.
  • 7 Collert S, Isacson J. Chronic sclerosing osteomyelitis (Garré). Clin Orthop Relat Res 1982; 164: 136-140 PMID: 7067276
  • 8 Jurik AG, Egund N. MRI in chronic recurrent multifocal osteomyelitis. Skeletal Radiol 1997; 26: 230-238 DOI: 10.1007/s002560050227.
  • 9 Azouz EM, Jurik AG, Bernard C. Sternocostoclavicular hyperostosis in children: a report of eight cases. AJR Am J Roentgenol 1998; 171: 461-466 DOI: 10.2214/ajr.171.2.9694476.
  • 10 Jurik AG, Møller BN. Chronic sclerosing osteomyelitis of the clavicle. A manifestation of chronic recurrent multifocal osteomyelitis. Arch Orthop Trauma Surg (1978) 1987; 106: 144-151 DOI: 10.1007/BF00452200.
  • 11 Andronikou S, Mendes da Costa T, Hussien M, Ramanan AV. Radiological diagnosis of chronic recurrent multifocal osteomyelitis using whole-body MRI-based lesion distribution patterns. Clin Radiol 2019; 74: 737.e3-737.e15 DOI: 10.1016/j.crad.2019.02.021.
  • 12 Sergi CM, Miller E, Demellawy DE, Shen F, Zhang M. Chronic recurrent multifocal osteomyelitis. A narrative and pictorial review. Front Immunol 2022; 13: 959575 DOI: 10.3389/fimmu.2022.959575.
  • 13 Hedrich CM, Hofmann SR, Pablik J, Morbach H, Girschick HJ. Autoinflammatory bone disorders with special focus on chronic recurrent multifocal osteomyelitis (CRMO). Pediatr Rheumatol Online J 2013; 11: 47 DOI: 10.1186/1546-0096-11-47.
  • 14 Leerling AT, Cañete AN, Ramautar AIE, Appelman-Dijkstra NM, Winter EM. Sternocostoclavicular hyperostosis: Positive clinical and radiological response on pamidronate. Front Endocrinol (Lausanne) 2021; 12: 621604 DOI: 10.3389/fendo.2021.621604.
  • 15 Roderick M, Shah R, Finn A, Ramanan AV. Efficacy of pamidronate therapy in children with chronic non-bacterial osteitis: disease activity assessment by whole body magnetic resonance imaging. Rheumatology (Oxford) 2014; 53: 1973-1976 DOI: 10.1093/rheumatology/keu226.
  • 16 Colina M, Trotta F. Antibiotics may be useful in the treatment of SAPHO syndrome. Mod Rheumatol 2014; 24: 697-698 DOI: 10.3109/14397595.2013.874760.
  • 17 Przepiera-Będzak H, Brzosko M. Clinical symptoms, imaging, and treatment of SAPHO syndrome: a single‑center study of 52 cases. Pol Arch Intern Med 2018; 128: 396-399 DOI: 10.20452/pamw.4261.
  • 18 Schilling F, Eckardt A, Kessler S. [Chronic recurrent multifocal osteomyelitis]. Z Orthop Ihre Grenzgeb 2000; 138: 530-539 German DOI: 10.1055/s-2000-9597.
  • 19 Aden S, Wong S, Yang C, Bui T, Higa T, Scheck J, Iyer RS, Egbert M, Lindberg A, Zhao Y. Increasing cases of chronic nonbacterial osteomyelitis in children: A Series of 215 cases from a single tertiary referral center. J Rheumatol 2022; 49: 929-934 DOI: 10.3899/jrheum.210991.
  • 20 Hetrick R, Oliver M. Pediatric autoinflammatory bone disorders-a mini review with special focus on pathogenesis and inborn errors of immunity. Front Pediatr 2023; 11: 1169659 DOI: 10.3389/fped.2023.1169659.
  • 21 Przepiera-Będzak H, Brzosko M. SAPHO syndrome: pathogenesis, clinical presentation, imaging, comorbidities and treatment: a review. Postepy Dermatol Alergol 2021; 38: 937-942 DOI: 10.5114/ada.2020.97394.
  • 22 Andronikou S, Kraft JK, Offiah AC, Jones J, Douis H, Thyagarajan M, Barrera CA, Zouvani A, Ramanan AV. Whole-body MRI in the diagnosis of paediatric CNO/CRMO. Rheumatology (Oxford) 2020; 59: 2671-2680 DOI: 10.1093/rheumatology/keaa303.
  • 23 Nico MAC, Araújo FF, Guimarães JB, da Cruz IAN, Silva FD, Carneiro BC, Filho AGO. Chronic nonbacterial osteomyelitis: the role of whole-body MRI. Insights Imaging 2022; 13: 149 DOI: 10.1186/s13244-022-01288-3.
  • 24 Aydıngöz Ü, Yıldız AE. MRI in the diagnosis and treatment response assessment of chronic nonbacterial osteomyelitis in children and adolescents. Curr Rheumatol Rep 2022; 24: 27-39 DOI: 10.1007/s11926-022-01053-x.
  • 25 Gupta AK, Skinner AR. A review of the use of infliximab to manage cutaneous dermatoses. J Cutan Med Surg 2004; 8: 77-89 DOI: 10.1007/s10227-004-0115-7.
  • 26 Massara A, Cavazzini PL, Trotta F. In SAPHO syndrome anti-TNF-alpha therapy may induce persistent amelioration of osteoarticular complaints, but may exacerbate cutaneous manifestations. Rheumatology (Oxford) 2006; 45: 730-733 DOI: 10.1093/rheumatology/kei221.
  • 27 Burgemeister LT, Baeten DL, Tas SW. Biologics for rare inflammatory diseases: TNF blockade in the SAPHO syndrome. Neth J Med 2012; 70: 444-449 PMID: 23230013.
  • 28 Kamata Y, Minota S. Successful treatment of a patient with SAPHO syndrome with certolizumab pegol. Rheumatol Int 2015; 35: 1607-1608 DOI: 10.1007/s00296-015-3263-8.
  • 29 Zhang L, Gao Z. Etanercept in the treatment of refractory SAPHO syndrome. Am J Clin Exp Immunol 2016; 5: 62-66 PMID: 28078192.
  • 30 Yang Q, Xiang T, Wu Y, Ye E, He B, Bu Z. SAPHO Syndrome with palmoplantar pustulosis as the first manifestation successfully treated with adalimumab. Clin Cosmet Investig Dermatol 2022; 15: 2547-2554 DOI: 10.2147/CCID.S384346.
  • 31 Sato H, Wada Y, Hasegawa E, Nozawa Y, Nakatsue T, Ito T, Kuroda T, Saeki T, Umezu H, Suzuki Y, Nakano M, Narita I. Adult-onset chronic recurrent multifocal osteomyelitis with high intensity of muscles detected by magnetic resonance imaging, successfully controlled with tocilizumab. Intern Med 2017; 56: 2353-2360 DOI: 10.2169/internalmedicine.8473-16.
  • 32 Cheng W, Li F, Tian J, Xie X, Chen JW, Peng XF, Tang Q, Ge Y. New Insights in the treatment of SAPHO Syndrome and medication recommendations. J Inflamm Res 2022; 15: 2365-2380 DOI: 10.2147/JIR.S353539.
  • 33 Leerling AT, Dekkers OM, Appelman-Dijkstra NM, Winter EM. Clinical and therapeutic diversity in adult chronic nonbacterial osteomyelitis (CNO) of the sternocostoclavicular region: a meta-analysis. Rheumatology (Oxford) 2023; 62: 512-522 DOI: 10.1093/rheumatology/keac443.